CHINA BIOLOGIC PRODS HLDGS I's ticker is and the CUSIP is G21515904. A total of 2 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $0 | -100.0% | 47 | -53.0% | 0.00% | -100.0% |
| Q4 2020 | $1,181,000 | +29.6% | 100 | +22.0% | 0.00% | +100.0% |
| Q3 2020 | $911,000 | +89.8% | 82 | +74.5% | 0.00% | 0.0% |
| Q2 2020 | $480,000 | -62.3% | 47 | -60.2% | 0.00% | -50.0% |
| Q1 2020 | $1,273,000 | -18.3% | 118 | -11.9% | 0.00% | -33.3% |
| Q4 2019 | $1,559,000 | -45.7% | 134 | -46.6% | 0.00% | -62.5% |
| Q3 2019 | $2,873,000 | +125.0% | 251 | +87.3% | 0.01% | +166.7% |
| Q2 2019 | $1,277,000 | +17.7% | 134 | +12.6% | 0.00% | 0.0% |
| Q1 2019 | $1,085,000 | -12.3% | 119 | -27.0% | 0.00% | -25.0% |
| Q4 2018 | $1,237,000 | -2.8% | 163 | +2.5% | 0.00% | 0.0% |
| Q3 2018 | $1,272,000 | -9.8% | 159 | +12.0% | 0.00% | -33.3% |
| Q2 2018 | $1,410,000 | – | 142 | +7000.0% | 0.01% | – |
| Q1 2018 | $0 | -100.0% | 2 | -88.9% | 0.00% | – |
| Q4 2017 | $2,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 47 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |